Biocon informs about analyst meet
Pursuant to Regulation 30(6) of the SEBI Listing Regulations, Biocon has informed that the Management of the Company is participating in the JP Morgan’s annual flagship India Credit Investor Trip on 11th March, 2026. The Company will not disclose any Unpublished Price Sensitive Information (UPSI) during the analyst(s)/ investor(s) meeting. The above information will also be available on the website of the Company at www.biocon.com.
The above information is a part of company’s filings submitted to BSE.
